The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia

Małgorzata Urban-Kowalczyk,1 Magdalena Kotlicka-Antczak,1 Dominik Strzelecki,1 Ewa Rudecka,2,3 Janusz Śmigielski4 1Department of Affective and Psychotic Disorders, Medical University of Łódź, Łódź, Poland; 2Babiński Memorial Hospital in Łódź, Łódź, Poland;...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Urban-Kowalczyk M, Kotlicka-Antczak M, Strzelecki D, Rudecka E, Śmigielski J
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/f22783bc95984fbd9e00099ac62bebdb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f22783bc95984fbd9e00099ac62bebdb
record_format dspace
spelling oai:doaj.org-article:f22783bc95984fbd9e00099ac62bebdb2021-12-02T12:02:12ZThe Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia1178-2021https://doaj.org/article/f22783bc95984fbd9e00099ac62bebdb2020-01-01T00:00:00Zhttps://www.dovepress.com/the-relationship-between-course-of-illness-and-beta-endorphin-plasma-l-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Małgorzata Urban-Kowalczyk,1 Magdalena Kotlicka-Antczak,1 Dominik Strzelecki,1 Ewa Rudecka,2,3 Janusz Śmigielski4 1Department of Affective and Psychotic Disorders, Medical University of Łódź, Łódź, Poland; 2Babiński Memorial Hospital in Łódź, Łódź, Poland; 3Faculty of Human Nutrition and Consumer Sciences, Warsaw University of Life Sciences SGGW, Warsaw, Poland; 4State High Vocational School in Konin, Konin, PolandCorrespondence: Małgorzata Urban-KowalczykDepartment of Affective and Psychotic Disorders, Medical University of Łódź, Czechosłowacka 8/10, Lodz 92-216, PolandTel +48 42 675 73 71Fax +48 42 675 74 03Email malgorzata.urban1@wp.plObjective: Extensive investigations have been conducted into predictors of schizophrenia outcome. The heterogeneity of the illness implies that many factors should be taken into account. Some studies have reported the relationship between increased β-endorphin concentration and predominant negative symptoms.Methods: We included 77 outpatients with schizophrenia and 74 healthy controls. Data referring to duration and course of illness, hospitalization number and treatment were collected on the basis of clinical interviews and medical documentation analysis. The β-endorphin concentrations were assessed once in all participants, at the onset of the study.Results: A chronic course of illness was found in 44 of the 77 schizophrenics. Patients with schizophrenia, especially those with a chronic course of illness, revealed significantly higher β-endorphin concentrations than those with an episodic course and controls (mean 29.70 vs 19.86 pmol/L; p=0.0001). Increased levels of β-endorphin were related to longer duration of illness (R=0.294, p=0.009) and frequent psychiatric hospitalization (R=0.346, p=–0.002).Conclusion: Endorphins may be potential biological predictors of persistent negative symptoms and final outcome in schizophrenia.Keywords: β-endorphin, dopamine, opioid peptides, schizophreniaUrban-Kowalczyk MKotlicka-Antczak MStrzelecki DRudecka EŚmigielski JDove Medical Pressarticleβ-endorphindopamineopioid peptidesschizophreniaNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 15, Pp 3609-3614 (2020)
institution DOAJ
collection DOAJ
language EN
topic β-endorphin
dopamine
opioid peptides
schizophrenia
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle β-endorphin
dopamine
opioid peptides
schizophrenia
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Urban-Kowalczyk M
Kotlicka-Antczak M
Strzelecki D
Rudecka E
Śmigielski J
The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia
description Małgorzata Urban-Kowalczyk,1 Magdalena Kotlicka-Antczak,1 Dominik Strzelecki,1 Ewa Rudecka,2,3 Janusz Śmigielski4 1Department of Affective and Psychotic Disorders, Medical University of Łódź, Łódź, Poland; 2Babiński Memorial Hospital in Łódź, Łódź, Poland; 3Faculty of Human Nutrition and Consumer Sciences, Warsaw University of Life Sciences SGGW, Warsaw, Poland; 4State High Vocational School in Konin, Konin, PolandCorrespondence: Małgorzata Urban-KowalczykDepartment of Affective and Psychotic Disorders, Medical University of Łódź, Czechosłowacka 8/10, Lodz 92-216, PolandTel +48 42 675 73 71Fax +48 42 675 74 03Email malgorzata.urban1@wp.plObjective: Extensive investigations have been conducted into predictors of schizophrenia outcome. The heterogeneity of the illness implies that many factors should be taken into account. Some studies have reported the relationship between increased β-endorphin concentration and predominant negative symptoms.Methods: We included 77 outpatients with schizophrenia and 74 healthy controls. Data referring to duration and course of illness, hospitalization number and treatment were collected on the basis of clinical interviews and medical documentation analysis. The β-endorphin concentrations were assessed once in all participants, at the onset of the study.Results: A chronic course of illness was found in 44 of the 77 schizophrenics. Patients with schizophrenia, especially those with a chronic course of illness, revealed significantly higher β-endorphin concentrations than those with an episodic course and controls (mean 29.70 vs 19.86 pmol/L; p=0.0001). Increased levels of β-endorphin were related to longer duration of illness (R=0.294, p=0.009) and frequent psychiatric hospitalization (R=0.346, p=–0.002).Conclusion: Endorphins may be potential biological predictors of persistent negative symptoms and final outcome in schizophrenia.Keywords: β-endorphin, dopamine, opioid peptides, schizophrenia
format article
author Urban-Kowalczyk M
Kotlicka-Antczak M
Strzelecki D
Rudecka E
Śmigielski J
author_facet Urban-Kowalczyk M
Kotlicka-Antczak M
Strzelecki D
Rudecka E
Śmigielski J
author_sort Urban-Kowalczyk M
title The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia
title_short The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia
title_full The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia
title_fullStr The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia
title_full_unstemmed The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia
title_sort relationship between course of illness and β-endorphin plasma levels in patients with schizophrenia
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/f22783bc95984fbd9e00099ac62bebdb
work_keys_str_mv AT urbankowalczykm therelationshipbetweencourseofillnessandbetaendorphinplasmalevelsinpatientswithschizophrenia
AT kotlickaantczakm therelationshipbetweencourseofillnessandbetaendorphinplasmalevelsinpatientswithschizophrenia
AT strzeleckid therelationshipbetweencourseofillnessandbetaendorphinplasmalevelsinpatientswithschizophrenia
AT rudeckae therelationshipbetweencourseofillnessandbetaendorphinplasmalevelsinpatientswithschizophrenia
AT smigielskij therelationshipbetweencourseofillnessandbetaendorphinplasmalevelsinpatientswithschizophrenia
AT urbankowalczykm relationshipbetweencourseofillnessandbetaendorphinplasmalevelsinpatientswithschizophrenia
AT kotlickaantczakm relationshipbetweencourseofillnessandbetaendorphinplasmalevelsinpatientswithschizophrenia
AT strzeleckid relationshipbetweencourseofillnessandbetaendorphinplasmalevelsinpatientswithschizophrenia
AT rudeckae relationshipbetweencourseofillnessandbetaendorphinplasmalevelsinpatientswithschizophrenia
AT smigielskij relationshipbetweencourseofillnessandbetaendorphinplasmalevelsinpatientswithschizophrenia
_version_ 1718394783822512128